Personal information

Pharmacokinetics, Modeling and simulation, Bioequivalence, Artificial Intelligence, Machine Learning, In silico clinical trials
Greece

Activities

Employment (1)

Ethniko kai Kapodistriako Panepistemio Athenon Schole Epistemon Ygeias: Athens, GR

Associate Professor (Department of Pharmacy)
Employment
Source: Self-asserted source
Vangelis D. Karalis

Education and qualifications (1)

National and Kapodistrian University of Athens: Athens, GR

2014 (Department of Pharmacy)
Education
Source: Self-asserted source
Vangelis D. Karalis

Works (50 of 64)

Items per page:
Page 1 of 2

Average Slope vs. Cmax: Which Truly Reflects the Drug-Absorption Rate?

Applied Sciences
2024-07 | Journal article | Author
Contributors: Maria Kokkali; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

A Vector Theory of Assessing Clinical Trials: An Application to Bioequivalence

Journal of Cardiovascular Development and Disease
2024-06 | Journal article | Author
Contributors: Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Bioequivalence Studies of Highly Variable Drugs: An Old Problem Addressed by Artificial Neural Networks

Applied Sciences
2024-06 | Journal article | Author
Contributors: Dimitris Papadopoulos; Georgia Karali; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Implementation of a Generative AI Algorithm for Virtually Increasing the Sample Size of Clinical Studies

Applied Sciences
2024-05 | Journal article | Author
Contributors: Anastasios Nikolopoulos; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Machine Learning in Allergic Contact Dermatitis: Identifying (Dis)similarities between Polysensitized and Monosensitized Patients

BioMedInformatics
2024-05 | Journal article | Author
Contributors: Aikaterini Kyritsi; Anna Tagka; Alexander Stratigos; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Type I Diabetes Mellitus Suppresses Experimental Skin Carcinogenesis

Cancers
2024-04 | Journal article | Author
Contributors: Maria Giakoumaki; George I. Lambrou; Dimitris Vlachodimitropoulos; Anna Tagka; Andreas Vitsos; Maria Kyriazi; Aggeliki Dimakopoulou; Vasiliki Anagnostou; Marina Karasmani; Heleni Deli et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Introducing an Artificial Neural Network for Virtually Increasing the Sample Size of Bioequivalence Studies

Applied Sciences
2024-03 | Journal article | Author
Contributors: Dimitris Papadopoulos; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

The Integration of Artificial Intelligence into Clinical Practice

Applied Biosciences
2024-01 | Journal article | Author
Contributors: Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Dried Blood Spots in Neonatal Studies: A Computational Analysis for the Role of the Hematocrit Effect

Pharmaceuticals
2023-08 | Journal article | Author
Contributors: Chrysa Daousani; Vangelis D. Karalis; Yannis L. Loukas; Kleopatra H. Schulpis; Konstantinos Alexiou; Yannis Dotsikas
Source: check_circle
Multidisciplinary Digital Publishing Institute

Variational Autoencoders for Data Augmentation in Clinical Studies

Applied Sciences
2023-07 | Journal article | Author
Contributors: Dimitris Papadopoulos; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

An In Silico Approach toward the Appropriate Absorption Rate Metric in Bioequivalence

Pharmaceuticals
2023-05 | Journal article | Author
Contributors: Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Modeling the Double Peak Phenomenon in Drug Absorption Kinetics: The Case of Amisulpride

BioMedInformatics
2023-03 | Journal article | Author
Contributors: Rania Kousovista; Georgia Karali; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222

Biomedicines
2022-02 | Journal article | Author
Contributors: Evangelos Terpos; Vangelis D. Karalis; Ioannis Ntanasis-Stathopoulos; Zoi Evangelakou; Maria Gavriatopoulou; Maria Manola; Panagiotis Malandrakis; DESPOINA GIANNIOU; Efstathios Kastritis; Ioannis Trougakos et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

The Pharmacokinetics of Levetiracetam in Critically Ill Adult Patients: An Intensive Care Unit Clinical Study

Applied Sciences
2022-01 | Journal article | Author
Contributors: Sophia-Liberty Markantonis; Nikolaos Markou; Apostolos Karagkounis; Dionysia Koutrafouri; Helen Stefanatou; Rania Kousovista; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals

Life
2021-10 | Journal article | Author
Contributors: Evangelos Terpos; Vangelis D. Karalis; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Sentiljana Gumeni; Panagiotis Malandrakis; Eleni-Dimitra Papanagnou; Efstathios Kastritis; Ioannis Trougakos; Meletios Dimopoulos
Source: check_circle
Multidisciplinary Digital Publishing Institute

3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications

Pharmaceutics
2021-09 | Journal article | Author
Contributors: Danae Karalia; Angeliki Siamidi; Vangelis D. Karalis; Marilena Vlachou
Source: check_circle
Multidisciplinary Digital Publishing Institute

High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events

Vaccines
2021-07 | Journal article | Author
Contributors: Evangelos Terpos; Marianna Politou; Ioannis Ntanasis-Stathopoulos; Vangelis D. Karalis; Efrosyni Merkouri; Despina Fotiou; Maria Gavriatopoulou; Panagiotis Malandrakis; Efstathios Kastritis; Ioannis Trougakos et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers

Cells
2021-07 | Journal article | Author
Contributors: Evangelos Terpos; Ioannis Trougakos; Vangelis D. Karalis; Ioannis Ntanasis-Stathopoulos; Sentiljana Gumeni; Filia Apostolakou ; Aimilia Sklirou; Maria Gavriatopoulou; Stamatia Skourti; Efstathios Kastritis et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Management of Acute Radiodermatitis in Non-Melanoma Skin Cancer Patients Using Electrospun Nanofibrous Patches Loaded with <i>Pinus halepensis</i> Bark Extract

Cancers
2021-05 | Journal article | Author
Contributors: Aikaterini Kyritsi; Stefanos Kikionis; Anna Tagka; Nikolaos Koliarakis; Antonia Evangelatou; Panagiotis Papagiannis; Alexandros Stratigos; Vangelis D. Karalis; Paraskevas Dallas; Andreas Vitsos et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Correlation between <i>Acinetobacter baumannii</i> Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models

Pathogens
2021-04 | Journal article | Author
Contributors: Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; George Ismailos; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Association of Antibiotic Use with the Resistance Epidemiology of <i>Pseudomonas aeruginosa</i> in a Hospital Setting: A Four-Year Retrospective Time Series Analysis

Scientia Pharmaceutica
2021-03 | Journal article | Author
Contributors: Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

An In Vitro–In Vivo Simulation Approach for the Prediction of Bioequivalence

Materials
2021-01 | Journal article | Author
Contributors: Marilena Vlachou; Vangelis D. Karalis
Source: check_circle
Multidisciplinary Digital Publishing Institute

Development of a joint population pharmacokinetic model of ezetimibe and its conjugated metabolite

European Journal of Pharmaceutical Sciences
2019 | Journal article
Contributors: K. Soulele; Vangelis Karalis
Source: check_circle
Web of Science Researcher Profile Sync

4CPS-077 Do we need to adopt antifungal stewardship programmes?

Section 4: Clinical Pharmacy Services
2018 | Journal article
Contributors: S Markantonis-Kyroudis; G Plakias; E Papadogeorgaki; S Sotiriou; F Kiospe; A Papachristos; I Scarlatinis; K Ioannidis; Vangelis Karalis
Source: check_circle
Web of Science Researcher Profile Sync

Laparoscopic total extraperitoneal inguinal hernia repair Retrospective study on prosthetic materials, postoperative management, and quality of life

Medicine
2018 | Journal article
Contributors: Konstantinos Konstantinidis; Panagiotis G. Athanasopoulos; Elina Schoina; Fotis Antonakopoulos; Periklis Chrysoheris; Sophia-Liberty Markantonis; Efi Georgiou; Vangelis Karalis
Source: check_circle
Web of Science Researcher Profile Sync

On the pharmacokinetics of two inhaled budesonide/formoterol combinations in asthma patients using modeling approaches

Pulmonary Pharmacology and Therapeutics
2018 | Journal article
Contributors: P. Macheras; K. Soulele; Vangelis Karalis
Source: check_circle
Web of Science Researcher Profile Sync

In vitro Controlled Release from Solid Pharmaceutical Formulations of two new Adamantane Aminoethers with Antitubercular Activity (I).

Drug Research
2017 | Journal article
Contributors: Thomas Mavromoustakos; Tahsin Kellici; Vangelis Karalis; Stewart Cole; Anthony Vocat; Angeliki-Sofia Foscolos; Violeta Kourbeli; V. Ioannidou; Ioannis Papanastasiou; Alexandra Iliopoulou et al.
Source: check_circle
Web of Science Researcher Profile Sync

In vitro Controlled Release of two new Tuberculocidal Adamantane Aminoethers from Solid Pharmaceutical Formulations (II)

Drug Research
2017 | Journal article
Contributors: Thomas Mavromoustakos; Tahsin Kellici; Vangelis Karalis; Markos-Orestis Georgiadis; Angeliki-Sofia Foscolos; Ioannis Papanastasiou; Konstantina Anastasiou; Polixeni Ladia; Dimitrios Lentzos; Dimitrios Spaneas et al.
Source: check_circle
Web of Science Researcher Profile Sync

Paediatric Medicines: Regulatory and Scientific Issues

Drug Research
2017 | Journal article
Contributors: Vangelis Karalis; Chrysa Daousani
Source: check_circle
Web of Science Researcher Profile Sync

Pharmacokinetic analysis of inhaled salmeterol in asthma patients: Evidence from two dry powder inhalers

Biopharmaceutics & Drug Disposition
2017 | Journal article
Contributors: Panos Macheras; Konstantina Soulele; Vangelis Karalis
Source: check_circle
Web of Science Researcher Profile Sync

GENERIC DRUGS- DO THEY OFFER THE SAME SAFETY AND EFFICACY AS ORIGINATOR MEDICINES? -PERCEPTIONS AND ATTITUDES OF FINAL YEAR PHARMACY STUDENTS IN GREECE

Value in Health
2016 | Journal article
Contributors: C Kani; S Markantonis; K Souliotis; C Gkinou; Vangelis Karalis
Source: check_circle
Web of Science Researcher Profile Sync

Ropivacaine, Interleukin-6 and Tumor Necrosis Factor Alpha Plasma Levels during Intermittent Epidural and Continuous Wound Infusion of Ropivacaine for Analgesia after Hysterectomy or Myomectomy: An Observational Study

Pharmacology
2016 | Journal article
EID:

2-s2.0-84988568964

Contributors: Markantonis, S.L.; Melemeni, A.; Markidou, M.; Haikali, S.I.; Karalis, V.; Fassoulaki, A.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Bioequivalence studies in Europe before and after 2010

Clinical Research and Regulatory Affairs
2015 | Journal article
EID:

2-s2.0-84928248274

Contributors: Daousani, C.; Karalis, V.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

From Bioequivalence to Biosimilarity: The Rise of a Novel Regulatory Framework

Drug Research
2015 | Journal article
EID:

2-s2.0-84953873052

Contributors: Karalis, V.D.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Population pharmacokinetics of fluticasone propionate/salmeterol using two different dry powder inhalers

European Journal of Pharmaceutical Sciences
2015 | Journal article
EID:

2-s2.0-84944516606

Contributors: Soulele, K.; Macheras, P.; Silvestro, L.; Rizea Savu, S.; Karalis, V.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

A non-binary biopharmaceutical classification of drugs: The ABΓ system

International Journal of Pharmaceutics
2014 | Journal article
EID:

2-s2.0-84896734515

Contributors: Macheras, P.; Karalis, V.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Generic products of antiepileptic drugs: A perspective on bioequivalence, bioavailability, and formulation switches using monte carlo simulations

CNS Drugs
2014 | Journal article
EID:

2-s2.0-84893449689

Contributors: Karalis, V.; MacHeras, P.; Bialer, M.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

On the statistical model of the two-stage designs in bioequivalence assessment

Journal of Pharmacy and Pharmacology
2014 | Journal article
EID:

2-s2.0-84891004847

Contributors: Karalis, V.; Macheras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

An insight into the properties of a two-stage design in bioequivalence studies

Pharmaceutical Research
2013 | Journal article
EID:

2-s2.0-84878854698

Contributors: Karalis, V.; Macheras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Exploring the relationships between scaled bioequivalence limits and within-subject variability

Journal of Pharmaceutical Sciences
2013 | Journal article
EID:

2-s2.0-84870691777

Contributors: Symillides, M.; Karalis, V.; Macheras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Keeping a critical eye on the science and the regulation of oral drug absorption: A review

Journal of Pharmaceutical Sciences
2013 | Journal article
EID:

2-s2.0-84881616061

Contributors: Macheras, P.; Karalis, V.; Valsami, G.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Quantitative assessment of the switchability of generic products

European Journal of Pharmaceutical Sciences
2013 | Journal article
EID:

2-s2.0-84883674084

Contributors: Karalis, V.; Bialer, M.; Macheras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

The role of the upper sample size limit in two-stage bioequivalence designs

International Journal of Pharmaceutics
2013 | Journal article
EID:

2-s2.0-84881623902

Contributors: Karalis, V.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

The role of the upper sample size limit in two-stage bioequivalence designs.

International journal of pharmaceutics
2013 | Journal article
EID:

2-s2.0-84899035805

Contributors: Karalis, V.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Bioequivalence of highly variable drugs: A comparison of the newly proposed regulatory approaches by FDA and EMA

Pharmaceutical Research
2012 | Journal article
EID:

2-s2.0-84862658878

Contributors: Karalis, V.; Symillides, M.; Macheras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Current regulatory approaches of bioequivalence testing

Expert Opinion on Drug Metabolism and Toxicology
2012 | Journal article
EID:

2-s2.0-84864038467

Contributors: Karalis, V.; MacHeras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1

Pediatric Infectious Disease Journal
2012 | Journal article
EID:

2-s2.0-84860238462

Contributors: Maltezou, H.C.; Drakoulis, N.; Siahanidou, T.; Karalis, V.; Zervaki, E.; Dotsikas, Y.; Loukas, Y.L.; Theodoridou, M.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Novel methods to assess bioequivalence

Expert Opinion on Drug Metabolism and Toxicology
2011 | Journal article
EID:

2-s2.0-78650491486

Contributors: Karalis, V.; Symillides, M.; MacHeras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

On the leveling-off properties of the new bioequivalence limits for highly variable drugs of the EMA guideline

European Journal of Pharmaceutical Sciences
2011 | Journal article
EID:

2-s2.0-80455143769

Contributors: Karalis, V.; Symillides, M.; MacHeras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier

Examining the role of metabolites in bioequivalence assessment

Journal of Pharmacy and Pharmaceutical Sciences
2010 | Journal article
EID:

2-s2.0-78650343186

Contributors: Karalis, V.; Macheras, P.
Source: Self-asserted source
Vangelis D. Karalis via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (147 reviews for 37 publications/grants)

Review activity for Advances in therapy. (3)
Review activity for Advances in therapy. (4)
Review activity for AI. (1)
Review activity for Antibiotics. (8)
Review activity for Applied sciences. (3)
Review activity for Bioengineering. (2)
Review activity for Biomedicines. (5)
Review activity for Biopharmaceutics & drug disposition. (2)
Review activity for British journal of clinical pharmacology (1)
Review activity for Data. (1)
Review activity for Diagnostics. (6)
Review activity for Drugs in R&D (1)
Review activity for European journal of clinical pharmacology. (1)
Review activity for European journal of clinical pharmacology. (3)
Review activity for Expert opinion on investigational drugs (2)
Review activity for Healthcare. (1)
Review activity for Information. (2)
Review activity for International journal for numerical methods in biomedical engineering. (2)
Review activity for International journal of environmental research and public health (1)
Review activity for International journal of molecular sciences. (1)
Review activity for Journal of cardiovascular development and disease. (2)
Review activity for Journal of clinical nursing. (1)
Review activity for Metabolites. (2)
Review activity for Molecules. (4)
Review activity for Multidisciplinary respiratory medicine. (1)
Review activity for Neurology and therapy. (2)
Review activity for Neurology and therapy. (1)
Review activity for Pathogens. (4)
Review activity for Pharmaceutical research. (1)
Review activity for Pharmaceutical research. (1)
Review activity for Pharmaceuticals. (12)
Review activity for Pharmaceutics. (51)
Review activity for Pharmacy. (3)
Review activity for SpringerPlus. (4)
Review activity for Statistics in medicine. (1)
Review activity for Vaccines. (3)
Review activity for Xenobiotica (4)